European Journal of Preventive Cardiology·26 SepAlcohol use disorder and cardiovascular risk in type 2 diabetes: beyond alcohol consumptionCohort study of 364,950 peopleAlcohol use disorderPaper
Bioactive Materials·18 Sep3D-printed PCL scaffold coated with chitosan-hyaluronic acid hydrogel loaded with NGF-overexpressing UiPSC-derived neural crest cells restores erectile function via cavernous nerve regenerationExperiments in animalsInterventionsPaper
Med·9 SepCardiovascular-kidney-metabolic syndrome and the risk of liver-related and cardiovascular events across the steatotic liver disease spectrumCohort study of 142,564 peopleSteatotic liver diseasePaper
Zhongguo Zhong Yao Za Zhi·3 SepScientific dietary model innovation based on homology of medicine and food and its application prospects in healthy agingReviewInterventionsPaper
Cancers·13 AugBody Roundness Index and Incident Colorectal Cancer Risk: A Nationwide Population-Based Cohort StudyCohort study in peopleColorectal cancerPaper
ADA Scientific Sessions 2026 Abstract·5 JunMetabolic, Hepatic, Renal, and Hemodynamic Effects of DA-2811 vs. Forxiga in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority StudyTrial in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunEfficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 25 mg in Patients with Type 2 Diabetes: A 24-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with 28-Week Open-Label ExtensionTrial in peopleInterventionsPaper